These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 16012420)
1. COX-2 inhibitors: pharmacological data and adverse effects. Mattia C; Coluzzi F Minerva Anestesiol; 2005; 71(7-8):461-70. PubMed ID: 16012420 [TBL] [Abstract][Full Text] [Related]
2. [What is new about nonsteroidal antiinflamatory drugs?]. Dzielska-Olczak M Pol Merkur Lekarski; 2007 Dec; 23(138):454-8. PubMed ID: 18432131 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular complications of non-steroidal anti-inflammatory drugs. Fosslien E Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252 [TBL] [Abstract][Full Text] [Related]
5. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs. Hur C; Chan AT; Tramontano AC; Gazelle GS Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man. Dajani EZ; Islam K J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633 [TBL] [Abstract][Full Text] [Related]
7. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain]. Bijlsma JW; Lems WF; van de Laar MA Ned Tijdschr Geneeskd; 2007 Apr; 151(14):795-8. PubMed ID: 17469317 [TBL] [Abstract][Full Text] [Related]
8. The use of NSAIDs in rheumatic disorders 2005: a global perspective. Kean WF; Buchanan WW Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966 [TBL] [Abstract][Full Text] [Related]
10. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain. Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859 [TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs]. van den Bemt BJ; Benraad HB; Rasker JJ Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414 [TBL] [Abstract][Full Text] [Related]
16. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Hermann M; Ruschitzka F Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196 [TBL] [Abstract][Full Text] [Related]
17. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do? Lazzaroni M; Battocchia A; Bianchi Porro G Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794 [TBL] [Abstract][Full Text] [Related]
18. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? Hersh EV; Lally ET; Moore PA Curr Med Res Opin; 2005 Aug; 21(8):1217-26. PubMed ID: 16083531 [TBL] [Abstract][Full Text] [Related]